Ackloo, S;
Antolin, AA;
Bartolome, JM;
Beck, H;
Bullock, A;
Betz, UAK;
Böttcher, J;
... Arrowsmith, CH; + view all
(2023)
Target 2035 - an update on private sector contributions.
RSC Medicinal Chemistry
10.1039/d2md00441k.
(In press).
Preview |
Text
d2md00441k.pdf - Published Version Download (1MB) | Preview |
Abstract
Target 2035, an international federation of biomedical scientists from the public and private sectors, is leveraging ‘open’ principles to develop a pharmacological tool for every human protein. These tools are important reagents for scientists studying human health and disease and will facilitate the development of new medicines. It is therefore not surprising that pharmaceutical companies are joining Target 2035, contributing both knowledge and reagents to study novel proteins. Here, we present a brief progress update on Target 2035 and highlight some of industry's contributions.
Archive Staff Only
 |
View Item |
